This Article contains a typographical error in the Results section under subheading ‘Identification of F12016 as a novel selective PPARγ agonist distinct from rosiglitazone’.
“The chemical name of F12016 is 2-[2-(1, 2-dimethyl-1H-indol-3-yl)-2-oxo-acetylamino]-benzamide, which has not been reported to show any activity.”
should read:
“The chemical name of F12016 is N-(2-acetylpheyl)-2-(1,2-dimethyl-1H-indol-3-yl)-2-oxoacetamide, which has not been reported to show any activity.”
Additional information
The online version of the original article can be found at 10.1038/srep09530
Rights and permissions
About this article
Cite this article
Liu, C., Feng, T., Zhu, N. et al. Correction: Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Sci Rep 5, 12185 (2015). https://doi.org/10.1038/srep12185
Published:
DOI: https://doi.org/10.1038/srep12185
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
